Table 1.
ACTUR1 | SEER2 | ACTUR:SEER | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Whites | Blacks | Whites | Blacks | Whites | Blacks | |||||||||||
Cancer site | Count | Rate3 | Rate 95%CI4 | Count | Rate3 | Rate 95%CI4 | Count | Rate3 | Rate 95%CI4 | Count | Rate3 | Rate 95%CI4 | IRR5 | IRR 95%CI | IRR5 | IRR 95%CI |
Men | ||||||||||||||||
Colorectum | 513 | 3.49 | 3.19-3.80 | 146 | 4.89 | 4.06-5.83 | 17642 | 4.22 | 4.09-4.35 | 2693 | 5.31 | 4.95-5.68 | 0.83 | 0.75-0.91 | 0.92 | 0.75-1.11 |
Lung | 277 | 1.85 | 1.63-2.08 | 70 | 2.49 | 1.91-3.20 | 20682 | 3.17 | 3.08-3.27 | 4957 | 7.21 | 6.83-7.60 | 0.58 | 0.51-0.66 | 0.35 | 0.26-0.45 |
Prostate | 689 | 4.32 | 4.00-4.65 | 221 | 10.02 | 8.64-11.57 | 35175 | 2.03 | 1.99-2.08 | 7576 | 4.80 | 4.60-5.01 | 2.12 | 1.95-2.30 | 2.09 | 1.77-2.43 |
Testis | 1756 | 12.63 | 12.05-13.23 | 70 | 1.97 | 1.54-2.50 | 9318 | 13.11 | 12.79-13.43 | 243 | 2.17 | 1.87-2.52 | 0.96 | 0.91-1.02 | 0.91 | 0.67-1.21 |
Women | ||||||||||||||||
Colorectum | 49 | 3.26 | 2.41-4.31 | 30 | 4.52 | 3.01-6.52 | 13051 | 3.41 | 3.29-3.53 | 2706 | 5.03 | 4.69-5.39 | 0.96 | 0.69-1.27 | 0.90 | 0.58-1.31 |
Lung | 30 | 1.99 | 1.34-2.84 | 25 | 4.70 | 2.78-7.33 | 17413 | 2.89 | 2.80-2.99 | 3031 | 4.27 | 3.99-4.56 | 0.69 | 0.45-0.98 | 1.10 | 0.62-1.73 |
Breast | 543 | 36.44 | 33.43-39.64 | 321 | 45.87 | 40.65-51.61 | 95058 | 30.62 | 30.29-30.96 | 12543 | 33.41 | 32.54-34.31 | 1.19 | 1.09-1.30 | 1.37 | 1.21-1.55 |
Cervical | 113 | 7.31 | 6.02-8.80 | 30 | 3.42 | 2.30-4.90 | 9308 | 7.92 | 7.70-8.14 | 1732 | 7.97 | 7.47-8.49 | 0.92 | 0.75-1.11 | 0.43 | 0.28-0.62 |
ACTUR, Automated Central Tumor Registry.
SEER, Surveillance, Epidemiology and End Results.
Rates are per 100,000 person-years and age-adjusted to active-duty military population aged 20-59.
Confidence interval.
Incidence rate ratio.